FDA Inspection 1164057 — AeroBiotix USA

AeroBiotix USA — FEI 3014151865

The FDA completed an inspection of AeroBiotix USA on March 9, 2022 in Miamisburg, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 9, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Compliance: Devices
Location
Miamisburg, OH (United States)

Citations

IDCFRDescription
367721 CFR 820.30(g)Design validation - software validation not performed
50221 CFR 820.60Identification procedures, Lack of or inadequate procedures